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Background: Studies of prenatal exposure to sex steroid hormones predict autistic traits in children at 18 to 24 and
at 96 months of age. However, it is not known whether postnatal exposure to these hormones has a similar effect.
This study compares prenatal and postnatal sex steroid hormone levels in relation to autistic traits in 18 to
24-month-old children.
Fetal testosterone (fT) and fetal estradiol (fE) levels were measured in amniotic fluid from pregnant women (n = 35)
following routine second-trimester amniocentesis. Saliva samples were collected from these children when they
reached three to four months of age and were analyzed for postnatal testosterone (pT) levels. Mothers were asked
to complete the Quantitative Checklist for Autism in Toddlers (Q-CHAT), a measure of autistic traits in children 18 to
24 months old.
Finding: fT (but not pT) levels were positively associated with scores on the Q-CHAT. fE and pT levels showed no
sex differences and no relationships with fT levels. fT levels were the only variable that predicted Q-CHAT scores.
Conclusions: These preliminary findings are consistent with the hypothesis that prenatal (but not postnatal)
androgen exposure, coinciding with the critical period for sexual differentiation of the brain, is associated with the
development of autistic traits in 18 to 24 month old toddlers. However, it is recognized that further work with a
larger sample population is needed before the effects of postnatal androgen exposure on autistic traits can be
ruled out. These results are also in line with the fetal androgen theory of autism, which suggests that prenatal,
organizational effects of androgen hormones influence the development of autistic traits in later life.Background
Autism Spectrum Conditions (ASC) occur more often in
males than females [1]. This sex difference may provide
an important clue to the etiology of the condition,
though the true sex ratio in ASC is unclear given the
known difficulties in the diagnosis of ASC in females [2].
ASC have strong neurobiological and genetic compo-
nents [3]; however, the specific factors (hormonal, ge-
netic or environmental) that are responsible for the
higher risk of ASC in males remain unclear.
Hormones perform critical functions in both neural and
physical development throughout life, from pregnancy to* Correspondence: ba251@cam.ac.uk
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reproduction in any medium, provided the oradolescence and beyond [4]. There are several lines of
evidence that suggest that prenatal exposure to hor-
mones, in particular fetal testosterone (fT), play a role in
the development of ASC. This includes the finding that
elevated fT is related to reduced eye contact [5], slower
language development [6], poorer quality of social rela-
tionships and narrower interests [7], and reduced em-
pathy [8]. Higher fT levels also predict increased
systemizing ability [9], and more autistic traits in
school-age children [10] and in toddlers [11].
To date, no studies have tested if there is also a link
between postnatal testosterone and the development of
autistic traits in later life. A possible window of interest
lies between three and four months of age, when a se-
cond peak in testosterone levels is thought to occur [12].
This second peak may play a significant role in physicalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tosterone, the estrogen hormone estradiol is another
hormone that is synthesized prenatally from testoste-
rone. Estradiol is considered to be the most biologically
active estrogen [15].
The aim of this study is to compare if prenatal and
postnatal sex steroid hormone levels in the same indivi-
duals are associated with differences in autistic traits at
18 to 24 months of age, using the Quantitative Checklist
for Autism in Toddlers (Q-CHAT).
Methods
Participants
Mothers were asked for consent to participate in research
at the time of having an amniocentesis. Medical records
of approximately 700 patients who had undergone amnio-
centesis in the Cambridge region between January 2004
and July 2006 were examined. Participants were excluded
if: (a) amniocentesis revealed a chromosomal abnormality;
(b) the pregnancy ended in miscarriage or termination;
(c) the child suffered neonatal or infant death; (d) the
child suffered significant medical problems after birth; (e)
there was a twin pregnancy or (f) the relevant informa-
tion was absent from medical records. General Practi-
tioners were asked for consent to contact the women, and
mothers with babies less than four months of age were
invited for participation (n = 104). This study was given
ethical approval by the National Health Service Suffolk
Research Ethics Committee. Written informed consent
was obtained from General Practitioners and participating
parents.
A total of n = 47 (22 boys, 25 girls) mothers brought
their children in for saliva collection, where a sample of
passive drool was taken when their child reached three-
months of age. Twelve samples had insufficient amounts
of saliva, with a total of 35 samples (15 boys, 20 girls)
remaining that were eligible for analysis. Saliva was col-
lected using a suction machine under the supervision ofTable 1 Descriptive statistics
Combined group Girls
Variable n M SD Range n M
fT level (nmol/L)** 35 0.58 0.45 0.05 to 2.28 20 0.34
fE level (nmol/L) 35 0.28 0.18 0.14 to 1.15 20 0.24
pT level (nmol/L) 35 0.17 0.06 0.02 to 0.29 20 0.18
Gestational age (weeks) 35 16.70 1.47 13 to 21.2 19 16.62
Child age (months) 35 19.34 2.93 18 to 35 20 19.10
Maternal age (years) 35 36.54 4.74 21 to 46 20 37.75
Parental education (1–5) 35 3.41 0.90 1.5 to 5 20 3.30
Q-CHAT score** 35 27.03 8.62 10 to 43 20 23.95
*Indicates raw values.
* Sex difference is significant at the P <0.05 level.
** Sex difference is significant at the P <0.01 level.a trained health professional. The families were con-
tacted when their child reached 18 months, and were
asked to complete the Q-CHAT [16]. Parents were blind
to both the fetal and postnatal hormone levels of their
child.
Outcome variable
The Quantitative Checklist for Autism in Toddlers (Q-
CHAT) is a 25-item parent-report screening measure
developed to identify toddlers at risk for the develop-
ment of ASC [16]. A total score is obtained with a mini-
mum score of 0 and a maximum score of 100 [16].
Hormone measurements
Fetal testosterone (fT) and fetal estradiol (fE) levels were
measured by radioimmunoassay in amniotic fluid. See
Auyeung et al. (2010) for details. Postnatal testosterone
(pT) levels were assayed (without separation or extrac-
tion) for testosterone from saliva samples using com-
mercially available immunoassay protocols (Salimetrics,
State College, PA, USA). Average intra- and inter-assay
coefficients of variation were 10% and 15%, respectively.
A serial dilution was performed (2.5) to give a standard
curve with greater sensitivity at lower ranges.
Demographic variables
Gestational age at amniocentesis (in weeks), maternal
age, parental education level, presence of older siblings
and the child’s age were included as control variables.
Finding
Levels of fE were positively skewed (skewness >1) so
natural logarithmic transformed data were used in sub-
sequent analyses. Distributions of the other variables
(including fT) were not skewed. The ranges of the Q-
CHAT scores obtained in this sample were consistent with
scores from a large sample of typically developing childrenBoys
SD Range n M SD range Cohen’s D
0.23 0.05 to 0.95 15 0.91 0.47 0.42 to 2.28 1.54
0.08 0.14 to 0.45 15 0.34 0.25 0.18 to 1.15 0.54
0.07 0.02 to 0.29 15 0.16 0.05 0.04 to 0.23 0.31
0.90 15 to 18.1 14 16.82 2.04 13 to 21.2 0.13
1.33 18 to 23 15 19.67 4.27 18 to 35 0.18
3.84 33 to 46 15 34.93 5.44 21 to 45 0.60
0.89 1.5 to 4.5 15 3.57 0.92 2 to 5 0.30
8.62 10 to 43 15 31.13 6.94 14 to 40 0.92
Table 3 Final regression model for Q-CHAT scores
Final regression model
Outcome Predictors R2 Δ R2 B SE β Sig
Group
Q-CHAT Score Maternal age 0.05 0.05 0.07 0.30 0.04 P >0.05
fT level 0.26 0.21 11.20 3.77 0.49 P <0.001
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for correlations.
Due to the small sample sizes, nonparametric statistics
were used to examine sex differences and correlation
values. Mann–Whitney U tests showed no significant
sex differences in pT levels (Mann–Whitney U = 127.5,
P >0.05) or fE levels (Mann–Whitney U = 101.0, P >0.05).
Significant sex differences were found for fT levels
(Mann–Whitney U = 24.0, P <0.001) and for Q-CHAT
score (Mann–Whitney U = 70.5, P <0.01). fT level and sex
were also significantly related (Spearman’s rho = 0.72,
P <0.001). However, no relationships between fT levels
and fE levels (Spearman’s rho = 0.03, P >0.05) were
found. In addition, no relationship was observed between
pT levels and sex (Spearman’s rho = −0.13, P >0.05),
between fT and pT levels (Spearman’s rho = 0.13, P >0.05)
or between pT levels and fE levels (Spearman’s rho = −0.11,
P >0.05). A significant relationship was observed between
fE levels and gestational age, but neither of these variables
were related to Q-CHAT scores.
A hierarchical multiple regression analysis was used.
In the first stage any predictor variable showing a signifi-
cant correlation with the outcome at P <0.20 was
included using the enter method [17]. Maternal age was
the only variable that met the P <0.20 criterion for entry
into the first stage (Spearman’s rho = −0.32, P <0.20).
The presence of suppressor variables (predictors that are
highly correlated with other predictors at P <0.01) was
investigated. However, no suppressor variables were
observed. The main effects of fT level, pT level and child
sex were tested for inclusion in the second stage using
the stepwise method (entry criterion P <0.05, removal
criterion P >0.10). The interaction between child sex, fT
level and the fT/pT interaction were tested for inclusion
in the third stage using the stepwise method (entry cri-
terion P <0.05, removal criterion P >0.10). fT level was
the only variable included in the final regression modelTable 2 Correlation matrix for all cases
fT level fE level pT level Sex Gest. age
fE Level .03 – – – –
pT Level .13 -.11 – – –
Sex .72** .28 -.13 – –
Gestational age .17 -.47** .10 .04 –
Child age -.08 .22 -.21 -.09 -.10
Maternal age -.40** -.09 -.18 -.28 .10
Parent education .03 .14 .31 .09 -.12
Older sister -.12 -.18 -.09 -.14 .02
Older brother -.08 .05 -.31 .02 -.10
Q-CHAT score .56** .17 -.09 .46** -.10
* P <0.05.
** P <0.01.and produced a significant F-change (F-change = 8.82,
P <0.01, ΔR2 = 0.21). Table 3 shows the regression
results for boys and girls together. See Figure 1 for
plots of the relationships between fT and Q-CHAT
scores and pT and Q-CHAT scores.
Within sex correlations are shown in Table 4. A sig-
nificant correlation between fT levels and Q-CHAT
scores was found for both boys (Spearman’s rho = 0.51,
P <0.05) and girls (Spearman’s rho = 0.57, P <0.05). No
significant relationships between fE, pT or any other
demographic variables and Q-CHAT scores were found
in boys or girls.
Discussion
This study examined relationships among fetal testoster-
one (fT), estradiol (fE), postnatal testosterone (pT) and
scores on the Quantitative Checklist for Autism in Tod-
dlers (Q-CHAT). Results confirmed earlier findings that
sex differences in autistic traits are present in toddlers,
with boys scoring much higher than girls [11,16]. fT
level was the only variable which was significantly
related to Q-CHAT scores when both sexes were com-
bined. However, no association was found between fT
levels and fE levels, between Sex and fE levels (r = −0.02,
P >0.05) or between Sex and pT levels. A correlation be-
tween fE levels and gestational age was found. However,
neither of these variables was related to Q-CHAT scores
suggesting that it is fT rather than fE or gestational age
that predicts Q-CHAT scores. Levels of postnatalChild age Matr. age Parent ed Older sister Older brother
– – – – –
– – – – –
– – – – –
– – – – –
– – – – –
.10 – – – –
.02 .01 – – –
.38 .32 -.07 – –
.18 -.04 .17 .03 –
.18 -.32 .09 -.01 .15
Figure 1 fT and pT levels and Q-CHAT scores.
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70% lower than in the second trimester and did not
show a significant effect on Q-CHAT score at 18 to 24
months.
In a regression model, fT level was the only predictor
retained in the final stage, whereas both Sex and the
fT/Sex interaction were excluded; suggesting this could
be an effect of fT, rather than Sex. Within Sex findings
also show significant correlations between Q-CHAT
score and fT level in boys and in girls. This corresponds
with related findings in larger samples both within this
age group and in older children [10,11].
The relationship observed between Q-CHAT scores
and fT level (but not pT level) provides preliminary
support for the notion that fetal rather than postnatal
exposure to testosterone is critical for the development
of autistic traits in toddlers. However, it is recognized
that this study has a limited sample size and that post-
natal testosterone should not be discounted as a factor
in the development of autistic traits until further testing
of these associations in a larger sample of children.Table 4 Correlation matrix for girls (above diagonal) and boy
fTlevel fElevel pT level Gest. age Child age
fT Level (nmol/L) – −0.32 0.22 0.45 0.20
fE Level (nmol/L) 0.10 – −0.40 −0.50* 0.41
pT Level (nmol/L) 0.43 0.44 – 0.46* −0.30
Gestational Age −0.19 −0.54* −0.27 – −0.29
Child Age −0.22 −0.04 −0.10 0.21 –
Maternal Age −0.44 −0.20 −0.04 0.30 −0.03
Parent Education −0.13 −0.07 −0.15 −0.37 −0.13
Older Sister −0.48 −0.16 0.27 0.10 0.26
Older Brother −0.38 −0.38 −0.42 0.08 0.12
Q-CHAT Score 0.51* −0.23 −0.09 0.04 −0.13
* P <0.05.Conclusions
The current study examined the link between prenatal
and postnatal hormone levels and later autistic traits.
The Q-CHAT is a validated measure of autistic traits,
which has been shown to differentiate toddlers who go
on to receive an ASC diagnosis later in childhood.
Results showed that fT levels are positively related to
Q-CHAT scores in this sample of typically developing
children. The lack of any relationship between pT or
fE levels and other variables (including Sex) indicates
that fetal exposure to testosterone has a greater in-
fluence on the development of autistic traits than expo-
sure to the same hormone after birth. The relationship
between fT levels and Q-CHAT scores remains consistent
with previous findings, despite the smaller sample of chil-
dren in this study. However, findings relating to pT re-
quire validation in a larger study. Although higher levels
of fT are unlikely to be the sole cause of autism, this work
aids our understanding of the potential mechanisms that
could contribute to the development of such conditions.
These results are in line with the fetal androgen theory ofs (below diagonal)
Matr. age Parent ed Older sister Older brother Q-CHAT score
−0.14 0.10 0.25 0.09 0.57*
0.13 0.17 −0.13 0.31 0.09
−0.41 0.60* −0.31 −0.21 −0.01
0.00 0.17 0.02 −0.27 −0.21
0.13 0.13 0.39 0.24 0.35
– −0.13 0.10 −0.23 −0.03
0.29 – −0.16 0.18 0.18
0.59 0.19 – −0.07 0.12
0.25 0.13 0.21 – 0.33
−0.39 −0.19 −0.27 −0.05 –
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the role of prenatal androgens in ASC is underway.
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